Patients who received subcutaneous 0.05% chlorhexidine gluconate antisepsis during primary total shoulder arthroplasty had a ...

Zoetis launches AI Masses, the new AI-powered cytologic capability for Vetscan Imagyst. News release. Zoetis. June 2, 2025.

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved ...

Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...

ZTS jumps 13% in a month as strong new product sales, strategic deals, and rising earnings estimates boost investor ...

Ascletis Pharma’s acne pill has scored a phase 3 win, leading the Chinese biotech to claim the Sagimet Biosciences-sourced ...

Despite its success in advanced melanoma, Bristol Myers Squibb’s fixed-dose PD-1/LAG-3 combo, Opdualag, failed to move the ...

The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.

The enzyme temporarily hydrolyses hyaluronan in the extracellular matrix of the subcutaneous layer of skin, making it possible to deliver larger volumes of drug material and improve dispersion and ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...

Opdivo Qvantig and Tecentriq Hybreza both rely on Halozyme's hyaluronidase technology, which temporarily hydrolyses hyaluronan in the extracellular matrix of the subcutaneous layer of skin ...